These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6166612)

  • 1. Preparation and characterization of detoxified lipopolysaccharide-protein conjugates.
    Seid RC; Sadoff JC
    J Biol Chem; 1981 Jul; 256(14):7305-10. PubMed ID: 6166612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pseudomonas aeruginosa polysaccharide-tetanus toxoid conjugate vaccine: safety and immunogenicity in humans.
    Cryz SJ; Sadoff JC; Fürer E; Germanier R
    J Infect Dis; 1986 Oct; 154(4):682-8. PubMed ID: 3091708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Essential regions of the lipopolysaccharide of Pseudomonas aeruginosa responsible for pyrogenicity and activation of the proclotting enzyme of horseshoe crabs. Comparison with antitumor, interferon-inducing and adjuvant activities.
    Tanamoto K; Homma JY
    J Biochem; 1982 Mar; 91(3):741-6. PubMed ID: 6804451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pseudomonas aeruginosa PAO-1 Lipopolysaccharide-Diphtheria Toxoid Conjugate Vaccine: Preparation, Characterization and Immunogenicity.
    Najafzadeh F; Shapouri R; Rahnema M; Rokhsartalab Azar S; Kianmehr A
    Jundishapur J Microbiol; 2015 Jun; 8(6):e17712. PubMed ID: 26301059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. O-polysaccharide-protein conjugates induce high levels of specific antibodies to Pseudomonas aeruginosa immunotype 3 lipopolysaccharide.
    van de Wiel PA; Witvliet MH; Evenberg D; Derks HJ; Beuvery EC
    Vaccine; 1987 Mar; 5(1):33-8. PubMed ID: 2437718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity comparison of conjugate vaccines composed of alginate and lipopolysaccharide of Pseudomonas aeruginosa bound to diphtheria toxoid.
    Najafzadeh F; Jaberi G; Shapouri R; Rahnema M; Karimi-Nik A; Kianmehr A
    Iran J Microbiol; 2014 Oct; 6(5):317-23. PubMed ID: 25848521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pseudomonas diminuta LPS with a new endotoxic lipid A structure.
    Kasai N; Arata S; Mashimo J; Akiyama Y; Tanaka C; Egawa K; Tanaka S
    Biochem Biophys Res Commun; 1987 Feb; 142(3):972-8. PubMed ID: 3827908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations in rats in vivo of the chemical structure of lipopolysaccharide from Salmonella abortus equi.
    Freudenberg MA; Galanos C
    Eur J Biochem; 1985 Oct; 152(2):353-9. PubMed ID: 4054113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemical composition and biological activity of lipopolysaccharides prepared from type strains of Campylobacter jejuni and Campolybacter coli.
    Naess V; Hofstad T
    Acta Pathol Microbiol Immunol Scand B; 1984 Aug; 92(4):217-22. PubMed ID: 6440410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological Properties of Exotoxin A Toxoid - Detoxified Lipopolysaccharide - Gold Nanoparticles Conjugate Against Pseudomonas aeruginosa Infection.
    Najafzadeh F; Tanomand A; Haddadi A; Majidi J
    Iran J Immunol; 2021 Dec; 18(4):292-303. PubMed ID: 34931615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chemical composition of the Pseudomonas solanecearum lipopolysaccharide].
    Drigues P; Lafforgue D; Asselineau J
    C R Seances Acad Sci III; 1982 Mar; 294(11):443-5. PubMed ID: 6807501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regions of the lipopolysaccharide of Pseudomonas aeruginosa essential for antitumor and interferon-inducing activities.
    Tanamoto K; Abe C; Homma JY; Kojima Y
    Eur J Biochem; 1979 Jul; 97(2):623-9. PubMed ID: 111929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of a common-antigen lipopolysaccharide from Pseudomonas aeruginosa.
    Rivera M; McGroarty EJ
    J Bacteriol; 1989 Apr; 171(4):2244-8. PubMed ID: 2495275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies of lipid A fractions from the lipopolysaccharides of Pseudomonas aeruginosa and Pseudomonas alcaligenes.
    Drewry DT; Lomax JA; Gray GW; Wilkinson SG
    Biochem J; 1973 Jul; 133(3):563-72. PubMed ID: 4200253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigenic epitope in Pseudomonas aeruginosa lipopolysaccharide immunologically cross-reactive with Escherichia coli O26 lipopolysaccharide.
    Yokota S; Kaya S; Noguchi H
    FEMS Microbiol Lett; 1990 Mar; 56(3):245-8. PubMed ID: 1692796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant properties of lipopolysaccharide from Neisseria meningitidis serogroup B detoxified and conjugated with tetanus toxoid.
    Balboa JA; Cuello M; Cabrera O; del Campo J; Lastre M; Gil D; Taboada C; Fariñas M; Hernández M; Pérez O
    Vaccine; 2006 Apr; 24 Suppl 2():S2-63-4. PubMed ID: 16823931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of selected antimicrobials on the viability, endotoxicity and lipopolysaccharide composition of Pseudomonas aeruginosa in vitro.
    Abraham M; Venter P; Lues JF; Ivanov I; de Smidt O
    Int J Antimicrob Agents; 2009 Nov; 34(5):419-23. PubMed ID: 19656661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutralization and lipoprotein binding of lipopolysaccharides in tolerant rabbit serum.
    Warren HS; Knights CV; Siber GR
    J Infect Dis; 1986 Nov; 154(5):784-91. PubMed ID: 3095436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemical characterization of lipopolysaccharides from Legionella feeleii, Legionella hackeliae and Legionella jordanis.
    Sonesson A; Jantzen E; Tangen T; Zähringer U
    Microbiology (Reading); 1994 Oct; 140 ( Pt 10)():2663-71. PubMed ID: 8000537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-pseudomonas activity of anti-lipopolysaccharide hyperimmune equine plasma.
    Wells M; Gaffin SL
    Clin Exp Immunol; 1987 Apr; 68(1):86-92. PubMed ID: 3115643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.